Related Experiment Videos
Summary
Hypophosphatemia, a common disorder affecting all organ systems, occurs when serum phosphate levels drop below 2.5 mg%. Treatment involves identifying at-risk patients, correcting causes, and supplementing phosphate, especially intravenously for severe cases.
Area of Science:
- Nephrology
- Endocrinology
- Internal Medicine
Background:
- Hypophosphatemia is a common disorder with serum phosphate levels below 2.5 mg%.
- It can affect virtually every organ system due to various causes like decreased intake, absorption, or increased loss.
- Phosphate deficiency necessitates prompt recognition and management.
Purpose of the Study:
- To outline the causes and consequences of hypophosphatemia.
- To present optimal therapeutic strategies for hypophosphatemia.
- To detail indications and empirical intravenous (IV) phosphate therapy for severe cases.
Main Methods:
- Review of literature on hypophosphatemia.
- Analysis of etiological factors contributing to phosphate deficiency.
- Guidelines for recognizing at-risk patients and correcting underlying abnormalities.
- Criteria for initiating intravenous phosphate supplementation.
Main Results:
- Hypophosphatemia results from decreased phosphate intake/absorption, increased renal/nonrenal losses, or transcellular shifts.
- Severe hypophosphatemia (serum phosphate < 1 mg%) requires intravenous phosphate therapy.
- Close monitoring of serum phosphate, calcium, potassium, and magnesium is crucial during IV therapy.
Conclusions:
- Optimal management of hypophosphatemia involves risk identification, addressing the root cause, and phosphate supplementation.
- Intravenous phosphate therapy is essential for severe hypophosphatemia.
- Adherence to monitoring guidelines ensures safe and effective treatment.